Showing results (281-290 of 395) with videos related to
Sort By:
Pageof 40
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2011
Analyses adjusting for selective crossover show improved overall survival with adjuvant letrozole compared with tamoxifen in the BIG 1-98 studyMarco Colleoni, Anita Giobbie-Hurder, Meredith M Regan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber ALL Consortium Protocol 87-01Jean Marie LeClerc, Amy L Billett, Richard D Gelber, et al.British Journal of Cancer|November 29, 2007
Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancerJ Bernhard, D Zahrieh, J J Zhang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Prognostic importance of thymidylate synthase expression in early breast cancerB C Pestalozzi, H F Peterson, R D Gelber, et al.JCO Precision Oncology|January 24, 2025
Genomic Characterization and Prognostic Significance of Human Epidermal Growth Factor Receptor 2-Low, Hormone Receptor-Positive, Early Breast Cancers From the BIG 1-98 and SOFT Clinical TrialsStephen J Luen, Lauren C Brown, Courtney T van Geelen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2015
Efficacy of Adjuvant Trastuzumab for Patients With Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer and Tumors ≤ 2 cm: A Meta-Analysis of the Randomized Trastuzumab TrialsCiara C O'Sullivan, Ian Bradbury, Christine Campbell, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2011
Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: long-term follow up on IBCSG Trial IXS Aebi, Z Sun, D Braun, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 18, 2011
Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancerP Karlsson, Z Sun, D Braun, et al.The Lancet. Oncology|September 10, 2018
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trialViviana Galimberti, Bernard F Cole, Giuseppe Viale, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 2009
Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trialM Rabaglio, Z Sun, K N Price, et al.Pageof 40